Medical Supply Sanctions Act of 2025

HR 4762, the Medical Supply Sanctions Act of 2025, prohibits the U.S. President from allowing the export of any FDA-approved drug or medical device (like prosthetics that replace or improve body parts) to Russia. This directly affects U.S. pharmaceutical and medical device companies that export these products. The ban remains in effect until the Secretary of State certifies to Congress that Russia has stopped military operations in Ukraine and withdrawn its forces. The law aims to restrict medical supplies to Russia as part of broader sanctions related to the Ukraine conflict.